George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2020 16:58

RNS Number : 0758U
4d Pharma PLC
24 July 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

4D PHARMA PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Steven Oliveira and connected parties

City and country of registered office (if applicable)

225 Via Palacio

Palm Beach Gardens

FL 33418

USA

4. Full name of shareholder(s) (if different from 3.)v

Name

South Ocean Capital Management, LLC

Steven Oliveira

South Ocean Capital, LLC

Nemean Asset Management, LLC

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

23/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

24/07/2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

13.04

0.00

13.04

131,392,242

Position of previous notification (if

applicable)

12.49

0.00

12.49

131,392,242

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares of £0.0025 each

 

17,127,145

0

13.04

0

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

South Ocean Capital Management LLC

7.61%

 

7.61%

Steven Oliveira

0.62%

 

0.62%

South Ocean LLC

0.47%

 

0.47%

Nemean Asset Management LLC

4.34%

 

4.34%

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional informationxvi

 

     

 

Place of completion

FL, USA

Date of completion

24 July 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFLFEEDDISFII
Date   Source Headline
19th Jul 20167:00 amRNSClinical Update
10th Jun 20167:00 amRNSClinical Update
23rd May 20164:40 pmRNSSecond Price Monitoring Extn
23rd May 20164:35 pmRNSPrice Monitoring Extension
23rd May 20162:35 pmRNSResult of AGM
23rd May 20167:00 amRNSClinical Update
22nd Apr 201610:49 amRNSAnnual Report and Notice of AGM
8th Apr 20167:00 amRNSAcquisition
31st Mar 20167:00 amRNSFinal Results
29th Feb 20164:40 pmRNSSecond Price Monitoring Extn
29th Feb 20164:35 pmRNSPrice Monitoring Extension
26th Feb 20167:00 amRNSClinical Update
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20167:00 amRNSAcquisition
22nd Jan 20167:00 amRNSChange of Registered Office
19th Jan 20167:00 amRNSClinical Update
4th Jan 20169:04 amRNSHolding(s) in Company
21st Dec 20153:44 pmRNSHolding(s) in Company
17th Dec 201510:21 amRNSHolding(s) in Company
17th Dec 201510:17 amRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:33 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSPlacing
3rd Dec 201512:38 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSResearch Update on MicroRx Discovery Platform
11th Nov 20157:00 amRNSClinical Trial Update
13th Oct 20157:00 amRNSHolding(s) in Company
30th Sep 20159:09 amRNSHolding(s) in Company
29th Sep 20157:00 amRNSInterim results for the period ended 30 June 2015
21st Aug 20157:00 amRNSClinical Trial Update
7th Aug 20157:00 amRNSResearch Collaboration
29th Jun 201510:56 amRNSResult of AGM
23rd Jun 20157:00 amRNSHolding(s) in Company
16th Jun 20157:00 amRNSResearch Update
5th Jun 20157:00 amRNSFinal Results
20th May 20157:00 amRNSResearch Update
22nd Apr 20152:48 pmRNSHolding(s) in Company
1st Apr 201510:53 amRNSHolding(s) in Company
30th Mar 20153:47 pmRNSAcquisition of minority interests
11th Feb 20153:38 pmRNSHolding(s) in Company
11th Feb 20152:28 pmRNSHolding(s) in Company
10th Feb 20154:04 pmRNSHolding(s) in Company
9th Feb 201510:17 amRNSResult of general meeting
21st Jan 20157:00 amRNSPlacing
7th Jan 20157:00 amRNSResearch Update
5th Jan 20157:00 amRNSResearch Update
6th Nov 20149:19 amRNSHolding(s) in Company
3rd Oct 201410:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.